Overview of the treatment of infant central nervous system tumors: medulloblastoma as a model.
Heideman
R L
RL
Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002066:Busulfan / Q000008:administration & dosage; D016190:Carboplatin / Q000008:administration & dosage; D016543:Central Nervous System Neoplasms / Q000401:mortality / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D016371:Cranial Irradiation / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000031:analogs & derivatives; D018572:Disease-Free Survival; D004806:Ependymoma / Q000401:mortality / Q000628:therapy; D005047:Etoposide / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008527:Medulloblastoma / Q000401:mortality / Q000628:therapy*; D015337:Multicenter Studies as Topic; D018242:Neuroectodermal Tumors, Primitive / Q000401:mortality / Q000628:therapy; D010865:Pilot Projects; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D012306:Risk; D015996:Survival Rate; D013852:Thiotepa / Q000008:administration & dosage; D019772:Topotecan / Q000008:administration & dosage; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
C048341:mafosfamide; D014750:Vincristine; D005047:Etoposide; D019772:Topotecan; D003520:Cyclophosphamide; D013852:Thiotepa; D016190:Carboplatin; D002066:Busulfan; D002945:Cisplatin